<DOC>
	<DOC>NCT01924104</DOC>
	<brief_summary>The purpose of the study is to determine whether low-dose aspirin and low molecular weight heparin improve the implantation and pregnancy rates in patients with repeated implantation failures in IVF cycle.</brief_summary>
	<brief_title>Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.</brief_title>
	<detailed_description>The investigators hypothesize that cotreatment of low dose aspirin &amp; low molecular weight heparin may improve implantation &amp; clinical pregnancy rates.</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<criteria>Aged between 19 to 35 years; Basal folliclestimulating hormone (FSH) levels of ≤8 IU/l Body mass index (BMI) between 19 kg/m2 and 25 kg/m2 Presence of both ovaries; ≥2 previous IVF failures Good quality embryos for transfer Endometrial thickness between 10 mm and 14 mm Polycystic ovary syndrome Endometriosis</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>IVF failure, implantation rate, heparin &amp; aspirin</keyword>
</DOC>